Correlation Between Apogee Therapeutics, and Fevertree Drinks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Fevertree Drinks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Fevertree Drinks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Fevertree Drinks Plc, you can compare the effects of market volatilities on Apogee Therapeutics, and Fevertree Drinks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Fevertree Drinks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Fevertree Drinks.

Diversification Opportunities for Apogee Therapeutics, and Fevertree Drinks

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Apogee and Fevertree is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Fevertree Drinks Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fevertree Drinks Plc and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Fevertree Drinks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fevertree Drinks Plc has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Fevertree Drinks go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Fevertree Drinks

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Fevertree Drinks. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 1.12 times less risky than Fevertree Drinks. The stock trades about -0.1 of its potential returns per unit of risk. The Fevertree Drinks Plc is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  849.00  in Fevertree Drinks Plc on November 3, 2024 and sell it today you would earn a total of  111.00  from holding Fevertree Drinks Plc or generate 13.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Fevertree Drinks Plc

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Fevertree Drinks Plc 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Fevertree Drinks Plc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Fevertree Drinks is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Apogee Therapeutics, and Fevertree Drinks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Fevertree Drinks

The main advantage of trading using opposite Apogee Therapeutics, and Fevertree Drinks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Fevertree Drinks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fevertree Drinks will offset losses from the drop in Fevertree Drinks' long position.
The idea behind Apogee Therapeutics, Common and Fevertree Drinks Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance